Epigral

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: INE071N01016
  • NSEID: EPIGRAL
  • BSEID: 543332
INR
929.85
-14.65 (-1.55%)
BSENSE

Nov 20

BSE+NSE Vol: 45.47 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1003523,
    "name": "Epigral",
    "stock_name": "Epigral",
    "full_name": "Epigral Ltd",
    "name_url": "stocks-analysis/epigral",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "929.85",
    "chg": -14.65,
    "chgp": "-1.55%",
    "dir": -1,
    "prev_price": "944.50",
    "mcapval": "4,029.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543332,
    "symbol": "EPIGRAL",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "indexname": "",
    "isin": "INE071N01016",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "45.47 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/epigral-1003523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Epigral Ltd is Rated Sell",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/epigral-ltd-is-rated-sell-4260696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/EpigralLtd_mojoScore_4260696.png",
        "date": "2026-11-13 10:10:45",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 November 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Epigral Ltd Surges 7.77% to Day's High of Rs 951 — Outperforms Sector by 5.4 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/epigral-ltd-hits-intraday-high-with-777-surge-on-11-nov-2026-4258356",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/EpigralLtd_priceRelatedfactors_4258356.png",
        "date": "2026-11-11 10:32:31",
        "description": "The Sensex advanced 1.49% on 11 Nov 2026, yet Epigral Ltd outpaced the broader market with a 7.77% gain, touching an intraday high of Rs 951. This 5.4 percentage-point outperformance over its Specialty Chemicals sector peers signals a distinctly stock-specific rally rather than a mere market tailwind."
      },
      {
        "title": "Epigral Ltd Surges 8.64% to Day's High of Rs 942.65 — Outperforms Sector by 6.98 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/epigral-ltd-hits-intraday-high-with-864-surge-on-2-nov-2026-4247840",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/EpigralLtd_priceRelatedfactors_4247840.png",
        "date": "2026-11-02 14:31:59",
        "description": "The Sensex advanced 0.98% on 2 Nov 2026, yet Epigral Ltd outpaced the broader market with an 8.64% gain, reaching an intraday high of Rs 942.65. This 6.98-percentage-point outperformance over its Specialty Chemicals sector peers marks a notable single-session surge that rewrites the short-term narrative for this small-cap stock."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-4246452",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/EpigralLtd_mojoScore_4246452.png",
        "date": "2026-11-01 10:10:05",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 01 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Epigral Ltd Falls 2.62% Amid Bearish Technical Signals and Underperformance",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/epigral-ltd-falls-262-amid-bearish-technical-signals-and-underperformance-4245637",
        "imagepath": "",
        "date": "2026-10-31 12:02:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens at Rs.887.40, down 1.15% amid broader market gains</p>\n                    <p><strong>27 Oct:</strong> Price rebounds to Rs.898.35 (+1.23%) following technical signals</p>\n                    <p><strong>29 Oct:</strong> Death Cross formation confirmed, signalling bearish trend</p>\n                    <p><strong>30 Oct:</strong> MarketsMOJO grade downgraded to Sell; stock closes at Rs.874.15 (-3.25%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.897.70</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-l..."
      },
      {
        "title": "Epigral Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/epigral-ltd-faces-bearish-momentum-amid-technical-downgrade-4243988",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/EpigralLtd_technicaldot_4243988.png",
        "date": "2026-10-30 08:02:36",
        "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a marked shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price currently hovers near ₹903.50, reflecting a subtle decline amid broader market pressures and deteriorating technical signals."
      },
      {
        "title": "Epigral Ltd Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/epigral-ltd-forms-death-cross-signalling-potential-bearish-trend-4243695",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/EpigralLtd_dealthcross_4243695.png",
        "date": "2026-10-29 18:01:12",
        "description": "Epigral Ltd, a small-cap player in the Specialty Chemicals sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and long-term weakness in the stock’s price trajectory."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-4231786",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/EpigralLtd_mojoScore_4231786.png",
        "date": "2026-10-21 10:10:19",
        "description": "Epigral Ltd is currently rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock's present position as of 21 October 2026, providing investors with the most recent and relevant data to assess the company’s outlook."
      },
      {
        "title": "Epigral Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/epigral-ltd-is-rated-sell-by-marketsmojo-4220874",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/EpigralLtd_mojoScore_4220874.png",
        "date": "2026-10-10 10:10:20",
        "description": "Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 28 September 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 October 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 90,
    "sid": "1003523",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/epigral-1003523"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "17-Nov-2026",
      "details": "One-on-One Meeting through Video Conferencing (V.C.) with Kitara Capital on Friday 20th November 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "17-Nov-2026",
      "details": "One-on-One Meeting through Video Conferencing (V.C.) with Kotak Mahindra Asset Management (Singapore) Pte Ltd on Thursday 19th November 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "07-Nov-2026",
      "details": "Epigral Limited submits Transcript of conference call held on Monday 2nd November 2026 discussing Q2 FY2027 Results.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Epigral Ltd has declared <strong>50%</strong> dividend, ex-date: 01 Jun 26",
          "dt": "2026-06-01",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

17-Nov-2026 | Source : BSE

One-on-One Meeting through Video Conferencing (V.C.) with Kitara Capital on Friday 20th November 2026.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

17-Nov-2026 | Source : BSE

One-on-One Meeting through Video Conferencing (V.C.) with Kotak Mahindra Asset Management (Singapore) Pte Ltd on Thursday 19th November 2026.

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

07-Nov-2026 | Source : BSE

Epigral Limited submits Transcript of conference call held on Monday 2nd November 2026 discussing Q2 FY2027 Results.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Epigral Ltd has declared 50% dividend, ex-date: 01 Jun 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available